Atlas Trials

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

Clinical trial NCT07215936 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07215936
Sponsor
Sohag University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2025-09-25
Primary completion
2027-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.